HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Trial treatment of chronic myeloid leukemia with 3 new chemotherapeutic agents: dibromomannitol, hydroxyurea and desacetamidocolchicine].

AuthorsA Cattan, M Schneider, L Schwarzenberg, J J Amiel, J R Schlumberger, E Gluckman, G Mathé
JournalLa semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris (Sem Hop) Vol. 42 Issue 49 Pg. 2966-9 (Nov 26 1966) France
Vernacular TitleEssai de traitement de la leucémie myéloïde chronique par 3 nouveaux composés chimiothérapiques: le dibromomannitol, l'hydroxyurée et la désacétamidocolchicine.
PMID4292624 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Mannitol
  • Urea
  • Colchicine
  • Hydroxyurea
Topics
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Colchicine (therapeutic use)
  • Female
  • Humans
  • Hydroxyurea (therapeutic use)
  • Leukemia, Myeloid (drug therapy)
  • Male
  • Mannitol (therapeutic use)
  • Urea (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: